Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone Infiltration for Quadratus Lumborum Syndrome
NCT03407027Phase 4Unknown
- Sponsor
- Hospital de Braga
- Start
- Nov 2017
- Primary completion
- Apr 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of triamcinolone in quadratus lumborum syndrome (3 arms), sponsored by Hospital de Braga. Primary endpoint: Efficacy of intervention at 3 months. Status: unknown.
02
Drugs
triamcinolone
03
Conditions
quadratus lumborum syndrome
Beyond the preview
Go deeper on NCT03407027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03407027.